Associate Director, Global Medical Oncology, Portfolio Delivery Lead at Bristol-Myers Squibb

Madison, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, OncologyIndustries

Requirements

Life sciences and/or healthcare professional training with an advanced degree (PharmD, MD, PhD, PA/NP)
Minimum of 3-5+ years working in the pharmaceutical industry with experience in Medical Affairs/Medical Strategy, Clinical Research preferred
Proven track record of collaborating cross-functionally to execute and deliver results in a fast-paced, deadline-driven environment while efficiently managing multiple priorities
Strong interpersonal and communication skills to navigate complex situations and gain alignment across diverse stakeholders
Highly organized and motivated with the ability to lead multiple projects and initiatives across diverse matrix teams
Fluency in digital tools, emerging technologies, and AI applications, with the ability to leverage these capabilities across projects, daily tasks, and decision-making
HQ based position with travel requirement approximately 20%

Responsibilities

Lead the execution of initiatives such as Advisory Boards, thought leader interactions, and congress encounters to collect insights and support shaping a portfolio-wide strategic plan for Medical Oncology
Collaborate with congress excellence team to align portfolio-wide congress booth strategy
Align with Medical Product Leads, Medical Communications, and Medical Societies Leads for oncology and hematology disease area portfolio-wide congress strategy
Develop and implement prioritized asset objectives and activities into oncology and hematology disease area strategic plans and implementation with key matrix stakeholders including Medical Societies and Patient Advocacy leads
Collaborate with Commercial and Access organizations to ensure appropriate alignment between commercial and asset medical activities
Provide strategic input to Medical Communications in aligning publication strategies and development of medical resources such as manuscripts, congress abstracts/posters/presentations, materials for symposia, training materials, field medical resources, reactive slide decks, and education

Skills

Portfolio Strategy

Stakeholder Management

Advisory Boards

Thought Leader Engagement

Congress Strategy

Medical Oncology

Hematology

Strategic Planning

Cross-Functional Collaboration

Insight Collection

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free